Nicholas Trum

Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series

British Journal of Dermatology · 2022 · First of 10 authors · 43 citations

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash

Case report · JAAD Case Reports · 2021 · First of 5 authors · 16 citations